Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy.
Taylor C, Hershman D, Shah N, Suciu-Foca N, Petrylak DP, Taub R, Vahdat L, Cheng B, Pegram M, Knutson KL, Clynes R.
Taylor C, et al. Among authors: petrylak dp.
Clin Cancer Res. 2007 Sep 1;13(17):5133-43. doi: 10.1158/1078-0432.CCR-07-0507.
Clin Cancer Res. 2007.
PMID: 17785568